Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

Published:2022-03-09 Issue:6 Volume:21 Page:853-866
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Bahji Anees¹²^ORCID,Zarate Carlos A.³,Vazquez Gustavo H.⁴

Affiliation:

1. Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

2. British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada

3. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

4. Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

Funder

Funding for this work was provided in part by the Intramural Research Program at the National Institute of Mental Health and the National Institutes of Health

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2047928

Reference135 articles.

1. Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission

2. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis

3. Diagnosis and definition of treatment-resistant depression

4. Defining treatment‐resistant depression

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depressive and Anxiety Disorders;International Encyclopedia of Public Health;2025

2. Comparative Short- and Long-Term Effectiveness and Safety of Pramipexole and Aripiprazole Augmentation in Treatment-Resistant Unipolar Depression: An Observational Study;Biomedicines;2024-09-10

3. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2);Journal of Psychiatric Research;2024-08

4. Novel treatments of depression: bridging the gap in current therapeutic approaches;Exploration of Neuroscience;2024-07-09

5. Role of Flt3l and Rps15 in ketamine anesthesia;Medicine;2024-03-01